Bank of America’s Neurotrope, Inc. Common NTRP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,344
| Closed | -$3K | – | 7569 |
|
|
2020
Q3 | $3K | Hold |
2,344
| – | – | ﹤0.01% | 6684 |
|
|
2020
Q2 | $3K | Hold |
2,344
| – | – | ﹤0.01% | 6645 |
|
|
2020
Q1 | $2K | Hold |
2,344
| – | – | ﹤0.01% | 6678 |
|
|
2019
Q4 | $2K | Sell |
2,344
-4,200
| -64% | -$3.27K | ﹤0.01% | 6928 |
|
|
2019
Q3 | $5K | Sell |
6,544
-8,000
| -55% | -$36.7K | ﹤0.01% | 6869 |
|
|
2019
Q2 | $117K | Hold |
14,544
| – | – | ﹤0.01% | 5928 |
|
|
2019
Q1 | $79K | Hold |
14,544
| – | – | ﹤0.01% | 5996 |
|
|
2018
Q4 | $52K | Hold |
14,544
| – | – | ﹤0.01% | 6206 |
|
|
2018
Q3 | $128K | Buy |
14,544
+8,000
| +122% | +$76.6K | ﹤0.01% | 5752 |
|
|
2018
Q2 | $63K | Hold |
6,544
| – | – | ﹤0.01% | 6021 |
|
|
2018
Q1 | $53K | Hold |
6,544
| – | – | ﹤0.01% | 6022 |
|
|
2017
Q4 | $46K | Hold |
6,544
| – | – | ﹤0.01% | 6098 |
|
|
2017
Q3 | $34K | Hold |
6,544
| – | – | ﹤0.01% | 6103 |
|
|
2017
Q2 | $61K | Hold |
6,544
| – | – | ﹤0.01% | 5797 |
|
|
2017
Q1 | $125K | Buy |
+6,544
| New | +$124K | ﹤0.01% | 5524 |
|
Other funds holding NTRP
Bank of America's NTRP Position: Q4 2020 in Review
Bank of America sold out of Neurotrope, Inc. Common (NTRP) in Q4 2020, closing a stake of 2,344 shares — an estimated $3K sold.
Bank of America first reported a position in NTRP in Q1 2017 and held it in 15 quarters. The position peaked at $128K in Q3 2018. 1 fund tracked by Wall St. Rank holds NTRP as of Q4 2020.
- Bank of America reported no remaining Neurotrope, Inc. Common position as of Q4 2020 after selling out during the quarter.
- Bank of America sold 2,344 Neurotrope, Inc. Common shares in Q4 2020, an estimated $3K.
- Bank of America first reported a position in Neurotrope, Inc. Common in Q1 2017 and held it in 15 quarters.
- Bank of America's Neurotrope, Inc. Common position peaked at $128K in Q3 2018.
- 1 fund tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q4 2020.
Based on Bank of America's 13F filing for Q4 2020, filed 10 Feb 2021.